Critical Care Literature, Curated

The week’s most important critical care research.

Twenty-six high-impact journals across critical care, pulmonary, cardiac, anesthesia, and healthcare leadership — NEJM, JAMA, The Lancet, AJRCCM, CCM, CHEST, ICM, Circulation, JACC, BMJ Leader, and more — auto-tagged by the ICCN editorial calendar. Refreshed every six hours.

60 articles

J Cardiothoracic & Vascular Anesthesia

Corrigendum to 'Comparison of Propofol-Based Total Intravenous Anesthesia versus Volatile Anesthesia with Sevoflurane for Postoperative Delirium in Adult Coronary Artery Bypass Grafting Surgery: A Prospective Randomized Single-Blinded Study', Journal of Cardiothoracic and Vascular Anesthesia, Volume 38, Issue 9, (2024), Pages 1932-1940

Varsha AV, Unnikrishnan KP, Babu MSS et al.

The Lancet

[Obituary] Bernard Roizman

Jacqui Thornton

Virologist and world authority on herpes simplex virus. Born on April 17, 1929, in Chișinău, Romania (now in Moldova), he died in Chicago, IL, USA, on April 13, 2026, aged 96 years.

The Lancet

[Editorial] Who owns cardiometabolic disease?

The Lancet

A person with obesity, type 2 diabetes, chronic kidney disease, metabolic dysfunction-associated steatotic liver disease, and heart failure might receive five different diagnoses, attend five different clinics, and be managed according to…

The Lancet

[Perspectives] Wintering in Davos

Sally Shuttleworth

Travel for health dates back to ancient times, but in the 19th century medical climatology emerged. The spa culture of the 18th century was largely displaced by a wider focus on the…

The Lancet

[Department of Error] Department of Error

Robb KA, Young B, Murphy MK, et al. Behavioural interventions to increase uptake of FIT colorectal screening in Scotland (TEMPO): a nationwide, eight-arm, factorial, randomised controlled trial. Lancet 2025; 405: 1081–92—In this…

The Lancet

[Department of Error] Department of Error

Coomarasamy A, Sindhu KN, Gallos I, et al. Postpartum haemorrhage: epidemiology, consequences, and missed opportunities. Lancet 2026; 408: 62–73—In this Series paper, data in table S7 of the appendix were incorrect and…

The Lancet

[Department of Error] Department of Error

GBD 2023 Cancer Collaborators. The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. Lancet 2025; 406: 1565–86—The…

NEJM

Klebsiella Brain Abscess and Evolution of Heterovirulence in the Urinary Tract

Christoph M. ErnstLilly K.S. FischerUniversity of Cologne, Cologne, GermanyAbigail L. MansonBroad Institute of MIT and Harvard, Cambridge, MALi LiMassachusetts General Hospital, BostonPeijun MaBroad Institute of MIT and Harvard, Cambridge, MAMelis N. AnahtarRoby P. BhattacharyyaMassachusetts General Hospital, BostonAshlee M. EarlBroad Institute of MIT and Harvard, Cambridge, MAAnne E. ClatworthyDeborah T. HungMassachusetts General Hospital, Boston

New England Journal of Medicine, Volume 395, Issue 4, Page 408-410, July 23, 2026. <br/>

NEJM

Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer

Matthew D. Galsky Begoña P. Valderrama Marco Maruzzo Albert Font Tudor Ciuleanu Jonathan Chatzkel Takuya Koie Christopher J. Hoimes Javier Puente Yousef Zakharia Eli Rosenbaum Katharina Boehm Yohann Loriot Jens Bedke Thomas B. Powles Andrea Necchi Pawel Wiechno Carlos Álvarez-Fernández Tae-Hwan Kim Niara Oliveira Thomas W. Flaig Heidi S. Wirtz Michael Mihm Qinlei Huang Aljosja Rogiers Blanca Homet Moreno and Alfonso Gómez de Liañothe KEYNOTE-B15/EV-304 Investigators*

New England Journal of Medicine, Volume 395, Issue 4, Page 338-348, July 23, 2026. <br/>

ICCN aggregates publicly available RSS metadata from peer-reviewed journals. All article content remains the property of the original publishers; full text is available at the source link. ICCN does not claim affiliation with or endorsement by the listed journals.